INCREASED CIRCULATING CYTOKINE RECEPTORS AND EX-VIVO INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1-BETA PRODUCTION BUT DECREASED TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AFTER A 5-KM RUN
Jph. Drenth et al., INCREASED CIRCULATING CYTOKINE RECEPTORS AND EX-VIVO INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1-BETA PRODUCTION BUT DECREASED TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AFTER A 5-KM RUN, European journal of clinical investigation, 28(10), 1998, pp. 866-872
Citations number
32
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
Background The purpose of this study was to examine the effect of a 5-
km run on blood leucocytes, acute-phase proteins and cytokines. In add
ition, cytokines were measured in the supernatants from whole-blood ce
ll cultures incubated with lipolysaccharide (LPS). Methods Ten healthy
, recreational trained, athletes (three women, seven men) volunteered
for this investigation. Samples were drawn just before, immediately af
ter and at 3 h, at 24h and at 48h after the race. Results Exercise ind
uced a transient leucocytosis (P = 0.0002) and a mild acute-phase reac
tion with increase in plasma C-reactive protein (CRP) (P = 0.0115) but
nor in serum amyloid A (SAA) concentrations. Although plasma interleu
kin 6 (IL-6) was undetectable and soluble interleukin-1 receptor type
II (IL-1sRII) remained unchanged, interleukin-1 receptor antagonist (I
L-1ra) concentrations were elevated directly after the race with a fur
ther increase at 3h (P<0.0001). Soluble tumour necrosis factor (TNF) r
eceptors were increased immediately after the run, but the effect was
more marked for sTNFr p55 (twofold increase; P<0.0001) than for sTNFr
p75 (1.16-fold increase; P=0.0007). In cell cultures, the LPS-induced
release of the inflammatory cytokines doubled for IL-1 beta (P < 0.000
1) and for IL-1ra (P < 0.0001). In contrast, TNF-oc production decreas
ed after the run, and a nadir was reached at 24h (P<0.0001). Conclusio
n These results suggest that a 5-km run elicits both the production of
acute-phase mediators (leucocytosis and elevation of CRP) and anti-in
flammatory counter-regulation as judged by the increase in circulating
concentrations of IL-1ra, sTNFr p55, and sTNFrp75 and down-regulation
of LPS-stimulated TNF-a! production.